6 insiders reported 20 Form 4 transactions for Ventyx Biosciences, Inc. (VTYX) over the past 18 months (most recent 2026-03-04). Recent activity: Forman Mark S (Chief Medical Officer) Sell 6,000 shares, Mohan Raju (CEO AND PRESIDENT) Sell 2.4M shares, Subramaniam Somu (Director) Sell 3.3M shares, Gonzales Roy (Senior VP, Finance) Sell 5,313 shares, GUJRATHI SHEILA (Director) Sell 130,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-04 | Forman Mark S | Chief Medical Officer | Sell | 6,000 | $0 |
| 2026-03-04 | Mohan Raju | CEO AND PRESIDENT | Sell | 2.4M | $0 |
| 2026-03-04 | Subramaniam Somu | Director | Sell | 3.3M | $0 |
| 2026-03-04 | Gonzales Roy | Senior VP, Finance | Sell | 5,313 | $0 |
| 2026-03-04 | GUJRATHI SHEILA | Director | Sell | 130,000 | $0 |
| 2026-03-04 | Nuss John | CHIEF SCIENTIFIC OFFICER | Sell | 489,481 | $0 |
| 2026-03-03 | Subramaniam Somu | Director | Sell | 694,718 | $0 |
| 2025-12-19 | Mohan Raju | CEO AND PRESIDENT | Buy | 116,668 | $0 |
| 2025-12-19 | Mohan Raju | CEO AND PRESIDENT | Sell | 47,345 | $365,503 |
| 2025-12-19 | Nuss John | CHIEF SCIENTIFIC OFFICER | Buy | 34,930 | $0 |
| 2025-12-19 | Nuss John | CHIEF SCIENTIFIC OFFICER | Sell | 12,675 | $97,851 |
| 2025-11-19 | Forman Mark S | Chief Medical Officer | Buy | 3,000 | $3,090 |
| 2025-11-19 | Gonzales Roy | Senior VP, Finance | Buy | 1,767 | $1,820 |
| 2025-05-16 | Forman Mark S | Chief Medical Officer | Buy | 3,000 | $3,090 |
| 2025-05-16 | Gonzales Roy | Senior VP, Finance | Buy | 1,750 | $1,802 |
| 2025-04-03 | Nuss John | CHIEF SCIENTIFIC OFFICER | Sell | 1,887 | $2,019 |
| 2025-04-01 | Mohan Raju | CEO AND PRESIDENT | Buy | 11,844 | $0 |
| 2025-04-01 | Nuss John | CHIEF SCIENTIFIC OFFICER | Buy | 4,531 | $0 |
| 2025-04-01 | Subramaniam Somu | Director | Sell | 1.3M | $0 |
| 2025-03-12 | Subramaniam Somu | Director | Sell | 1.7M | $0 |
Source: SEC Form 4 filings · as of 2026-03-04